Search results for "papilloma"

showing 10 items of 266 documents

Erratum to “Prognostic factors of recurrent respiratory papillomatosis spread to lower airway passages” [Int. J. Pediatr. Otorhinolaryngol. 68 (2004)…

2005

medicine.medical_specialtyOtorhinolaryngologybusiness.industryPediatrics Perinatology and Child HealthINTmedicineGeneral MedicineRecurrent Respiratory PapillomatosisAirwaybusinessDermatologyInternational Journal of Pediatric Otorhinolaryngology
researchProduct

HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV)

2020

Human papillomavirus (HPV) related cervical cancer represents an issue of public health priority. The World Health Organization recommended the introduction of HPV vaccination in all national public programs. In Europe, vaccines against HPV have been available since 2006. In Italy, vaccination is recommended and has been freely offered to all young girls aged 11 years since 2008. Three prophylactic HPV vaccines are available against high- and low-risk genotypes. The quadrivalent vaccine contains protein antigens for HPV 6, 11, 16, and 18. The bivalent vaccine includes antigens for HPV 16 and 18. The nonavalent vaccine was introduced in 2014, and it targets HPV types 6, 11, 16, 18, 31, 33, 4…

medicine.medical_specialtyPathologycervical cancerprimary preventionImmunologylcsh:MedicineReviewHPV vaccinescervical intraepithelial neoplasiaCervical intraepithelial neoplasia03 medical and health sciences0302 clinical medicineDrug DiscoverymedicinePharmacology (medical)030212 general & internal medicineYoung adulthuman papillomavirusHPV vaccinePharmacologyColposcopyCervical cancermedicine.diagnostic_testbusiness.industryPublic healthlcsh:Rmedicine.diseaseVaccinationClinical trialSettore MED/40 - GINECOLOGIA E OSTETRICIAInfectious Diseases030220 oncology & carcinogenesisbusinessVaccines
researchProduct

[Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)].

2014

Introduction: In 2009, two cases of seizures in adolescents following quadrivalent human papillomavirus vaccine (qHPV) administration generated important media attention, and adversely affected public trust in this vaccine. Our objectives were to describe suspected adverse reactions (SARs) reported to the Pharmacovigilance Centre in the Valencian Community (PCVC) after administration of HPV vaccine, and to compare reporting rates of syncope and seizures following this vaccine with those of other vaccines administered to girls aged 13–15 years. Materials and methods: Descriptive study of SARs reported following administration of this vaccine to the PCVC between 2007 and 2011. Results: The cl…

medicine.medical_specialtyPediatricsHuman papillomavirusTime FactorsAdolescentVirus del papiloma humanoVaccines AdministeredHuman papillomavirus vaccinePediatricsRJ1-570Valencian communitySyncopeReporting ratePharmacovigilanceHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18SeizuresManagement of Technology and InnovationPharmacovigilanceMedicineHumansRetrospective StudiesbiologyVacunabusiness.industryReacción adversaSyncope (genus)PharmacovigitanceTasa de notificaciónbiology.organism_classificationSurgeryVaccinationFarmacovigilanciaSpainFemalebusinessAdverse reactionsVaccineAnales de pediatria (Barcelona, Spain : 2003)
researchProduct

Prevalence of human papillomavirus in the saliva of sexually active women with cervical intraepithelial neoplasias

2020

Background The main objective of this study was to estimate the prevalence of human papillomavirus-DNA (HPV-DNA) in the saliva of sexually active women with HPV-related cervical intraepithelial neoplasias (CIN) and compare the findings with a healthy control group. The secondary objectives were: 1) to determine the concordance between genital and oral HPV types in sexually active women with HPV-related CIN; 2) to analyze whether sexual habits influence the presence of HPV-related CIN; 3) to determine whether sexual habits influence the presence of oral HPV. Material and Methods Saliva samples were collected from 100 sexually active women, 50 with HPV-related CIN and 50 healthy subjects pres…

medicine.medical_specialtySalivaConcordanceUterine Cervical NeoplasmsCervical intraepithelial neoplasialaw.invention03 medical and health sciencesSexually active0302 clinical medicineCondomRisk FactorslawPrevalencemedicineHumansSex organPapillomaviridaeSalivaPapillomaviridaeGeneral DentistryOral Medicine and PathologybiologyObstetricsbusiness.industryResearchPapillomavirus Infectionsvirus diseases030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Uterine Cervical Dysplasiabiology.organism_classificationmedicine.diseasefemale genital diseases and pregnancy complicationsOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASMarital statusFemaleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Human Papillomavirus (HPV) Detection in Keratotic Variants of Oral Lichen Planus: Negative Results in a Preliminary Open Study

2017

Background During the last few decades, several researches have been identified HPV genomic sequences in Head Neck Squamous Cell Carcinomas (HNSCC) and in Oral Potentially Malignant Disorders (OPMD) hypothesizing a possible viral etiological role. However, the reported prevalence of HPV-DNA (varying from 0% to 100%) in these lesions result still very discordant. Objective Human papillomavirus (HPV) infection in Oral Lichen Planus (OLP) has been largely investigated but not so extensively with respect to its morphological/histopathological features. The possible influence of hyper-keratosis/parakeratosis in HPV detection for keratotic variants of OLP is here proposed and investigated. Materi…

medicine.medical_specialtybusiness.industry030206 dentistryGeneral MedicineHpv detectionmedicine.diseaseDermatologyOpen study03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisMedicineOral lichen planusHPV Keratotic Variants Oral lichen planusHuman papillomavirusbusinessARC Journal of Dental Science
researchProduct

Papillomatosis Gougerot und Carteaud als ektodermale Randsymptomatik bei segment�rer Lipodystrophie

1963

Beschreibung einer Gougerot-Carteaudschen Papillomatose, die bisher ausschlieslich im Bereiche einer segmentaren Fettverteilungsstorung nach Art der progressiven Lipodystrophie zur Ausbreitung gekommen ist. Unter Hinweis auf annahernd vergleichbare Hautbegleiterscheinungen bei anderen vorzugsweise mesenchymalen Konstitutionsabweichungen (z. B. dem Marfan- oder dem Ehlers-Danlos-Syndrom) werden die papillomatosen Veranderungen als ektodermale Randsymptome gewertet.

medicine.medical_specialtybusiness.industrymedicinePapillomaDermatologyGeneral MedicinePapillomatosismedicine.symptomLipodystrophymedicine.diseasebusinessDermatologyArchiv f�r Klinische und Experimentelle Dermatologie
researchProduct

EXPERIENCE OF REMOVING BENIGN NEOPLASMS OF SKIN IN CERVICOFACIAL AREA USING THE METHOD OF PLASMA ABLATION

2017

Choosing appropriate methods for removal of benign skin lesions (BSL) in the cervicofacial area has always been an important and challenging issue. Removal of the BSL is indicated and performed for medical and aesthetic reasons. A method with less painful procedures, a short healing period, without noticeable long-lasting traces (such as scars, dyschromia) and, predictably, fewer repeat procedures is preferred. Objectives. Evaluation of the effectiveness, safety and convenience of BSL plasma ablation using Plexr® (GMV, Italy); Comparison of the reparative processes speed after the BSL removal in the cervicofacial area applying the Plexr® device with other instrumental methods (based on lite…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentScarsmedicine.diseaseAblationSurgeryXanthelasmamedicine.anatomical_structureMiliaSyringomaDyschromiamedicinePapillomaEyelidmedicine.symptombusinessVestnik dermatologii i venerologii
researchProduct

The vaccinaTion & Hpv Knowledge (THinK) questionnaire: a reliability and validity study on a sample of women living in Sicily (southern-Italy)

2019

Objective The aim of this study was to introduce the VaccinaTion & Hpv Knowledge (THinK) questionnaire to assess knowledge about human papillomavirus (HPV) and attitude to HPV-vaccination. Its reliability and validity was demonstrated in a sample of women living in Sicily (southern Italy). Methods A cross-sectional survey was conducted on a sample of 220 women at the “Paolo Giaccone” University Hospital in Palermo (Sicily), aged 18–61. Data were analyzed through Cronbach’s alpha and exploratory factor analysis, followed by a structural equation model with measurement component. The two-level data structure was explicitly considered. Results Three dimensions were found: “knowledge of HP…

medicine.medical_specialtylcsh:MedicineGeneral Biochemistry Genetics and Molecular BiologyStructural equation modelingValidity03 medical and health sciences0302 clinical medicineCronbach's alphamedicineMultilevel structural equation modelGeneral knowledge030212 general & internal medicineReliability (statistics)QuestionnaireGeneral Neurosciencelcsh:RVaccinationHPV infectionGeneral MedicinePapillomavirusPapillomavirumedicine.diseaseExplained variationReliabilityExploratory factor analysisVaccinationKnowledgeAttitude030220 oncology & carcinogenesisFamily medicineGeneral Agricultural and Biological SciencesPsychology
researchProduct

Prevalence and Risk Factors for Anal Human Papillomavirus Infection in Human Immunodeficiency Virus–Positive Men Who Have Sex with Men

2018

A correction has been published:The Journal of Infectious Diseases, Volume 218, Issue 8, 15 October 2018, Page 1350, https://doi.org/10.1093/infdis/jiy315; International audience; Background:We assessed prevalence and risk factors for anal human papillomavirus (HPV) in human immunodeficiency virus (HIV)-positive men who have sex with men (MSM), who are at high-risk of HPV-related anal cancer.Methods:APACHES is a multicentric, prospective study of anal HPV infection and lesions in HIV-positive MSM aged ≥35 years. At baseline, participants underwent anal swabs for HPV and cytology, plus high-resolution anoscopy. High-risk HPV (HR-HPV) was tested by Cobas4800, with genotyping of HR-HPV positiv…

medicine.medical_specialtymen who have sex with menMen who have sex with men03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyAnal cancer030212 general & internal medicineanal canalProspective cohort studyhuman papillomavirusGenotypinghigh-resolution anoscopy[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologymedicine.diagnostic_testhuman immunodeficiency virusbusiness.industryHPV infectionAnoscopyvirus diseasesOdds ratio16. Peace & justicemedicine.diseaseConfidence intervalfemale genital diseases and pregnancy complications3. Good healthInfectious Diseases030220 oncology & carcinogenesisbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Induction of Type-Specific Neutralizing Antibodies by Capsomeres of Human Papillomavirus Type 33

2001

Abstract The immunogenicity of capsomeres of human papillomavirus type 33 was evaluated in a dose–response analysis. Capsomeres were obtained free of capsids by expression of L1 carrying the single point mutation C427S. Neutralizing antibodies were detected using an in vitro pseudoinfection assay. Capsomeres induced type-specific, neutralizing antibodies in mice even in the absence of adjuvant. The neutralization titers of immune sera raised without adjuvant were 10- to 20-fold lower than those of antisera to virus-like particles, but virtually identical using Freund's adjuvant. These data indicate that capsomeres may substitute for virus-like particles in future vaccines when used with an …

medicine.medical_treatmentDose-Response Relationship ImmunologicEnzyme-Linked Immunosorbent AssayAntibodies ViralpapillomavirusNeutralizationMiceCapsidNeutralization Testsdose responseVirologymedicineAnimalsHumansPapillomaviridaeAntiserumMice Inbred BALB CbiologyImmunogenicityCapsomereVirionneutralizationvaccinationVirologyTiterCapsidbiology.proteincapsomeresImmunizationAntibodyAdjuvantVirology
researchProduct